UNSPSC 51401518: Diazepam

This classification denotes a benzodiazepine with the molecular formula C16H13ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q3JTX2Q7TU, chemically known as 7-chloro-1-methyl-5-phenyl-3h-1,4-benzodiazepin-2(1h)-one but generally known as diazepam, which bears US NIH Compound Identifier 3016. European Medicines Agency schedules Diazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07069MIG.

UNSPSC 51401518 Diazepam is a Commodity code tracking pharmaceutical procurement by state and local governments. Recent opportunities show substantial activity in opioid-response medications and broad-spectrum generic pharmaceutical supply contracts rather than diazepam specifically. State and local buyers under this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances sourcing branded and generic pharmaceuticals, controlled substances, and over-the-counter products for distribution across public health facilities, emergency response programs, and employee health benefit plans. Issuing bodies range from individual counties to statewide cooperative purchasing vehicles serving multiple jurisdictions across regions.

Procurement activity concentrates in Florida and Minnesota with multistate reach. Representative opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to community health facilities, with electronic bidding through the county's e-Procurement Portal and compliance requirements including drug-free workplace certification and E-Verify; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) gathering vendor capabilities for direct-to-manufacturer prescription programs to support pharmacy benefit management outside traditional PBM and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with awards effective July 1, 2026, and price competitiveness weighted at 75 percent of evaluation.